Lucid Diagnostics gets notice of allowance for patent underlying its esoguard esophageal DNA test
seekingalpha
2024-10-15
7postman/E+ via Getty Images
Lucid Diagnostics (NASDAQ:LUCD) and subsidiary of PAVmed (NASDAQ:PAVM) received a Notice of Allowance from the United States Patent and Trademark Office.
The notice is for a patent application covering its proprietary method of using methylation of the cyclin-A1 gene to